According to the DEA, they hold the ultimate decision-making power to schedule, reschedule, or deschedule a drug according to the Controlled Substances Act. They explain that the decision was made after considering relevant statutory and regulatory criteria and the scientific and medical evaluation conducted by the Department of Health and Human Services (HHS). Currently, the DEA is actively conducting its comprehensive review.”